← Evidence map

ArticleBone marrow transplantation2026

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD.

Yibo Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41876848